Roivant Sciences Ltd Earnings

The next earnings date for Roivant Sciences Ltd is August 6, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of Roivant Sciences Ltd Earnings

Report DateEstimated Earnings Per Share
11/17/2025$-0.30
08/06/2025$-0.25

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Roivant Sciences Ltd Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
02/11/2025Before Market$-0.2017.17%
11/12/2024Before Market$-0.31-20.38%
08/08/2024Before Market$0.12146.15%
05/30/2024Before Market$-0.1936.67%
02/13/2024Before Market$-0.306.25%
11/13/2023Before Market$-0.40-29.03%
08/14/2023Before Market$-0.38-26.67%
06/28/2023Before Market$-0.2044.44%
02/13/2023Before Market$-0.49-25.64%
11/14/2022Before Market$-0.420.00%
08/15/2022Before Market$-0.48-50.00%
06/28/2022Before Market$-0.2715.63%
02/14/2022Before Market$-0.41-64.00%
11/15/2021Before Market$-0.32-45.45%
09/21/2021After Market$-0.28---
05/20/2021---$0.37---
03/22/2021---$-0.01---
11/19/2020---$0---
06/30/2020---$-0.02---
03/31/2020---$-0.25---

More About Roivant Sciences Ltd

Country
USA
Full Time Employees
750

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, the United Kingdom.

Roivant Sciences Ltd Earnings” Can Refer to the Roivant Sciences Ltd Earnings Date

Some people say “Roivant Sciences Ltd earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Roivant Sciences Ltd position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Roivant Sciences Ltd Stock on the Earnings Date

If you own Roivant Sciences Ltd stock (ROIV) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Roivant Sciences Ltd might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Roivant Sciences Ltd shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Roivant Sciences Ltd Earnings

You can contact us any time if you would like to ask questions about Roivant Sciences Ltd earnings or anything else related to the stock market.